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Abstract 
Background: The overexpression of key enzymes in a metabolic pathway is a frequently used genetic engineer-
ing strategy for strain improvement. Metabolic control analysis has been proposed to quantitatively determine key 
enzymes. However, the lack of quality data often makes it difficult to correctly identify key enzymes through control 
analysis. Here, we proposed a method combining in vitro metabolic pathway analysis and proteomics measurement 
to find the key enzymes in threonine synthesis pathway.
Results: All enzymes in the threonine synthesis pathway were purified for the reconstruction and perturbation of 
the in vitro pathway. Label-free proteomics technology combined with APEX (absolute protein expression measure-
ments) data analysis method were employed to determine the absolute enzyme concentrations in the crude enzyme 
extract obtained from a threonine production strain during the fastest threonine production period. The flux control 
coefficient of each enzyme in the pathway was then calculated by measuring the flux changes after titration of the 
corresponding enzyme. The isoenzyme LysC catalyzing the first step in the pathway has the largest flux control coeffi-
cient, and thus its concentration change has the biggest impact on pathway flux. To verify that the key enzyme identi-
fied through in vitro pathway analysis is also the key enzyme in vivo, we overexpressed LysC in the original threonine 
production strain. Fermentation results showed that the threonine concentration was increased 30% and the yield 
was increased 20%.
Conclusions: In vitro metabolic pathways simulating in vivo cells can be built based on precise measurement of 
enzyme concentrations through proteomics technology and used for the determination of key enzymes through 
metabolic control analysis. This provides a new way to find gene overexpression targets for industrial strain 
improvement.
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Background
The goal of metabolic engineering is the rational design 
and modification of cellular metabolism for the produc-
tion of useful biochemicals and bioenergy. Due to the 
complexity of a metabolic network and its regulation, 
the construction of a highly efficient cell factory often 
requires alteration from various aspects, such as intro-
ducing heterologous enzymes with high activity, over-
expression of key enzymes, deleting genes leading to 
byproducts, sequence modification for the removal of 
end product inhibition or repression and applying evolu-
tionary engineering strategies [1, 2]. The overexpression 
of key enzymes in the pathway to a desired product is 
often necessary for strain improvement. Several meth-
ods based on genome scale metabolic network analy-
sis such as flux balance analysis and FVSEOF have been 
proposed for the identification of gene amplification 
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targets [3–6]. However, as these methods are just based 
on reaction stoichiometry, all genes in a linear pathway 
will have equal contribution to the pathway flux and thus 
these methods will not be able to identify which enzymes 
are more important for increasing the pathway flux. A 
theoretical method called metabolic control analysis has 
been developed to quantitatively measure the impact of 
an enzyme on the pathway flux through flux control coef-
ficients (FCCs) [7]. FCCs (Ci) is mathematically defined 
according to the large deviation theory [8].
where J r and Eri  represent the enzyme activity and flux of 
the system after enzyme concentration or activity chang-
ing, while ∆J  is the flux change and ∆Ei is the change of 
enzyme activity. The large FCC value implies that the 
change in the enzyme concentration will lead to a big 
change in flux. FCCs of enzymes in a pathway can be cal-
culated if a kinetic model is available for the pathway [9–
11]. However, the quality of the kinetic models will greatly 
affect the metabolic control analysis results. Many kinetics 
models are developed based on individual enzyme kinet-
ics which measure how metabolite concentrations affect 
transient enzyme rates rather than how enzyme concen-
trations affect the steady state pathway flux in a multi-
enzyme system. Therefore metabolic control analysis from 
such kinetic models may not reveal the true key enzymes.
Experimental determination of FCC is possible by 
measuring the flux changes after perturbation on enzyme 
concentrations. A number of studies have dealt with the 
relationships between the flux of a metabolic system in 
vivo and the concentrations and activities of particu-
lar enzymes with the use of genetic means to alter the 
enzyme parameters [12, 13]. However, the in vivo stud-
ies usually confront difficulties in precise manipulation 
and measurement of enzyme concentrations. In contrast, 
alteration of enzyme concentrations in a cell free in vitro 
system is much easier if purified enzymes are available. 
The in vitro method bypasses cell walls and removes 
genetic regulation to enable direct access to the inner 
workings of the cell. Due to the unprecedented level of 
control and freedom of design, relative to in vivo systems, 
it has been widely studied for the production of biocom-
modities and bioelectricity in recent years [14–16]. In 
addition, in vitro analysis methods have also been used to 
guide the genetic engineering of strains for optimization 
of fatty acid, fatty alcohol and farnesene synthesis process 
[17–19].
One issue in using an in vitro system is that the 
enzyme concentrations must be similar with the in vivo 
system so that the key enzymes identified from in vitro 






Intracellular protein concentrations could be measured 
through various proteomics technologies, which usually 
involve proteolysis of protein mixtures, followed by anal-
ysis of the peptides generated using chromatography and 
mass spectrometry (MS). However, due to the difference 
in size and amino acid composition of proteins, normal 
proteomics data is often suitable for comparing protein 
levels at different conditions but not for cross-protein 
comparison. To address this problem, Lu et al. [20] pro-
posed a method called absolute protein expression meas-
urements (APEX) to get the relative protein ratios from 
proteomics data. APEX relies upon correcting each pro-
tein’s mass spectrometry sampling depth (observed pep-
tide count) by learned probabilities for identifying the 
peptides, like background expectation of observing each 
peptide in the experiment, the total sampling depth and 
the confidence in protein identification. And it is a robust 
and rapid method to quantify protein abundance without 
requiring construction of fusion protein libraries, labe-
ling or internal standards. This method has been widely 
used for protein expression measurements [21–23].
In this research, we used label- free proteomics and 
APEX method to determine the absolute protein concen-
trations in a threonine production E. coli strain named 
Thr. Based on the data, we designed an in vitro multi-
enzyme system to experimentally measure the FCCs 
of enzymes in threonine synthesis pathway. The results 
indicate that LysC, one of the isoenzymes of aspartate 
kinase, is the key enzyme for increasing threonine syn-
thesis flux. We then overexpressed the lysC gene in the 
production strain and the threonine yield in the new 
strain was improved.
Results and discussion
Characterization of the crude enzyme extract and enzyme 
purification
The five-step metabolic pathway for threonine synthesis 
from aspartate in E. coli is shown in Figure  1. The first 
step (aspartate kinase) was catalyzed by three isoen-
zymes: ThrA, LysC and MetL. In wild type strain, these 
three isoenzymes are inhibited by threonine, lysine and 
methionine respectively [20]. However, genome sequence 
analysis of our threonine production strain revealed 
a mutant in ThrA which removes threonine inhibi-
tion (unpublished data). To investigate the contribution 
of different isoenzymes to the first reaction, the crude 
enzyme extract obtained from the cells at 12 h was used. 
From the fermentation time course shown in Figure  2, 
we can see that the cells at 12 h were at the exponential 
growth phase and the threonine production was also at 
the highest rate. In vitro analysis at this period could be 
more helpful for identifying the true bottleneck for fur-
ther improvement of threonine synthesis flux in vivo. We 
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added 10  mM lysine and 10  mM methionine which is 
enough to inhibit the corresponding isoenzyme [24, 25] 
to the crude enzymes extract separately and checked the 
aspartate kinase activity change. As shown in Figure  3, 
there was almost no activity change when methionine 
was added, implying that the contribution of MetL is 
neglectable. When 10 mM lysine was added the reaction 
rate was reduced from 8.52 to 3.85 μM/min, indicating 
that LysC, usually responsible for lysine synthesis, made 
an even higher contribution toward threonine synthesis 
than the mutated ThrA in the production strain. There-
fore, we purified LysC and ThrA as well as the other three 
enzymes in the threonine synthesis pathway (Asd, ThrB 
and ThrC). SDS-PAGE of these five enzymes was shown 
in Figure 4, from this figure we can see that all the puri-
fied enzymes were in the correct molecule weights and 
were relatively pure. We also measured the activities 
of the purified enzymes to make sure they were active 
enzymes. Figure 5a was the chromatogram of homoser-
ine and threonine standards (the concentrations were 
Figure 1 Threonine synthesis pathway from aspartate in E. coli. The reactions are catalyzed by aspartate kinase (ThrA, MetL, LysC), aspartate 
semialdehyde dehydrogenase (Asd), homoserine dehydrogenase (ThrA), homoserine kinase (ThrB) and threonine synthase (ThrC). ASA aspartic 
β-semialdehyde, aspartyl-P β-aspartyl phosphate.
Figure 2 Fermentation process of threonine production stain. The 
cells sampled at 12 h (exponential growth phase and with high threo-
nine production rate) were used for proteomics analysis and crude 
enzyme extract experiments. Two replicates of this experiment.
Figure 3 Contribution of the three isoenzymes on aspartate kinase 
activity in the crude enzyme extract. Control: representing the 
summed activity of all three isoenzymes; LysC, ThrA and MetL; Lysine: 
representing the activity of ThrA and MetL after the addition of Lysine 
to inhibit LysC; Methionine: representing the activity of ThrA and LysC 
after the addition of Methionine to inhibit MetL. Three replicates of 
this experiment.
Figure 4 SDS-PAGE of the purified threonine synthesis enzymes.
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both 1 mM), the peak at about 7.0 min was homoserine 
and the peak at about 7.4 min was threonine. Figure 5b 
showed the chromatogram of reaction with purified 
enzymes, two obvious peaks of homoserine and threo-
nine could be seen which demonstrated that all of the 
purified enzymes were active. Figure 5c was the chroma-
togram of the reaction with crude enzyme extracts, and 
two peaks at the same time could be seen, so we could get 
the conclusion that all enzymes of threonine synthesis 
pathway in the crude enzyme extract were active.
Determination of the absolute enzyme concentrations
The MS data were processed using Pioplite software with 
protein identification and quantification. APEX method 
was used to process the original label-free proteomics 
data to get reliable data on ratios between different pro-
teins. We chose to focus on the enzymes in the threonine 
synthesis pathway and the relative amount of enzymes 
(normalized to LysC) was shown in Figure  6. To deter-
mine the absolute enzyme concentrations, we need to 
measure the absolute enzyme concentration for at least 
one enzyme. We chose to measure Asd concentration in 
the crude extract as NADPH is involved in its catalyzed 
reaction and thus the reaction rate (proportional to the 
enzyme concentration) can be easily measured through 
fluorescent. We added different amount of purified Asd 
into the diluted (1:40) crude extract and measured the 
reaction rates. As can be seen from the result shown in 
Figure 7, a good linear relationship between the reaction 
rate and added Asd concentration was obtained. The Asd 
concentration in the diluted crude extract was calculated 
to be 15  nM from the linear relationship (the intersec-
tion on X-axis) and from the dilution rate we estimated 
that the absolute Asd concentration in the crude enzyme 
extract was 600 nM. As in the process of crude enzyme 
extraction, we added 10 mL enzyme assay buffer to about 
0.66 mg pellet cells, the cells were diluted about 15 times. 
Therefore, the absolute concentration of Asd in the cells 
was about 9  μM. Combined with the relative enzyme 
ratio determined by proteomics, absolute concentra-
tions for all enzymes in the pathway were calculated and 
shown in Table  1. The concentration values were in the 
same order of magnitude with the integrated concen-
tration data from PaxDb database [25] which contains 
absolute protein concentrations from several proteomics 
studies on E. coli [20, 26–29].
Key enzymes in the threonine synthesis pathway
Key enzymes in a metabolic pathway can be determined 
by comparing the flux control coefficients. With the deter-
mination of the absolute enzyme concentrations in the 
crude extract and the availability of the purified enzymes, 
we were able to measure the FCCs in vitro by titration of 
Fig. 5 HPLC analysis of metabolites. a Peaks from the standard metabolites of homoserine and threonine, the left peak represents homoserine and 
the right peak represents threonine. b Homoserine and threonine produced in the in vitro reaction system by purified enzymes. c Homoserine and 
threonine produced in the in vitro reaction system constituted by crude enzyme extracts.
Figure 6 Relative ratio of the enzymes in the threonine synthesis 
pathway. Original proteomics data was processed by APEX method. 
And the relative amounts of enzymes in threonine synthesis pathway 
were normalized to LysC. Three replicates of this experiment.
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purified enzymes into the crude extract. Based on meta-
bolic control analysis theory, the impact of an enzyme 
on the pathway flux should be measured when the sys-
tem reaches a steady state. However, a true steady state 
can only be obtained in continuously operated enzymatic 
reactors which are difficult to construct and operate. Fre-
quently, a pseudo-steady state in batch reactor to calculate 
the flux through a pathway exists [17]. Here we also used 
a batch reactor to calculate the flux through the threonine 
pathway. The metabolites added to the reaction system 
include: 5 mM ASP, 5 mM ATP, 10 mM NADPH, 0.5 mM 
PLP. All substrate concentrations were much higher than 
their Km values so that the reaction rates would not be 
affected by the decreased substrate concentrations dur-
ing the batch reaction process. To evaluate the impact of 
different enzymes, we added individual purified enzymes 
into the reaction system so that the concentration of the 
corresponding enzyme was increased two times. Figure 8 
showed the measured threonine concentration changes 
over time with addition of LysC and the reaction system 
without addition of purified enzymes was used as con-
trol. Good linear relationships indicate the existence of 
pseudo-steady state during that time period and the path-
way fluxes (J) can be calculated from the slope values of 
the regression line. From Figure 8b the pathway flux after 
addition of two times LysC was 0.0111 mM/min, while the 
flux of the control was only 0.0082 mM/min (Figure 8a). 
Other pathway flux changes were shown in Additional file 
(see Additional file 1: Figure S1). After the addition of puri-
fied enzymes, all pathway fluxes were increased but at dif-
ferent extent, indicating the different impact of enzymes. 
Based on the definition of FCC from large deviations 
theory [8], the FCCs of different enzymes were calculated 
from the pathway flux changes and shown in Figure 9. The 
flux control coefficients of LysC and ThrA were higher 
than the other three enzymes, implying that the first step 
of threonine synthesis was the control step for threonine 
synthesis from aspartate. This result is in agreement with 
the normal biochemistry knowledge that the first step of 
a pathway is often the rate limiting step, but is in contrast 
with the result from modeling analysis by Chassagnole and 
his colleagues [10]. They found that Asd rather than ThrA 
was the enzyme with the largest FCC. This may imply that 
some parameters (such as enzyme concentrations) used 
in their model might be wrong. In our research, we used 
the enzyme concentrations obtained from proteomics 
analysis of real high threonine production cells, and thus 
the key enzymes identified are more likely to be the true 
key enzymes in the cells. Interestingly, our analysis showed 
that the control coefficient of LysC was even larger than 
that of ThrA. This means that LysC is an even better gene 
overexpression target.
In vivo validation of the key enzyme
To demonstrate the effect of overexpression of the 
enzyme LysC on the threonine production we genetically 
engineered a new strain with a plasmid containing lysC. 
The engineered strain produced approximately 30% more 
threonine compared with the original strain, and the 
threonine yield was increased from 40 to 50% (Figure 10). 
This demonstrated that LysC, the key enzyme identified 
through in vitro metabolic control analysis, was indeed a 
limiting step and a successful target for increasing threo-
nine production.
Figure 7 Determination of Asd absolute concentration in the crude 
enzyme extract. Different amounts of purified Asd were added into 
the diluted crude extract and the reaction rates were measured. The 
Asd concentration in the diluted crude extract was calculated from 
the intersection on X-axis and from the dilution rate the absolute 
Asd concentration in the crude enzyme extract was calculated. Three 
replicates of this experiment.
Table 1 Measured absolute enzyme concentrations in E. 
coli cells
a The concentrations from PaxDb [25] were the integrated concentration data 
from several proteomics studies. The protein concentrations cited here were 
recalculated to convert the unit from ppm to μM. The average volume of E. coli 
was set at 0.6 μm3 [30] and the average number of proteins in E. coli was set at 
2.5 × 106 [20].




LysC 3.24 ± 0.32 3.32
ThrA 13.09 ± 0.71 5.31
ASD 9.01 ± 0.65 12.44
ThrB 6.27 ± 0.42 5.17
ThrC 12.78 ± 0.61 7.10
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Conclusions
In this study, a method combining proteomics meas-
urement and in vitro metabolic pathway analysis was 
proposed to determine the key enzymes in threonine 
synthesis pathway. The precise measurement of absolute 
enzyme concentrations in producing cells and the possi-
bility of accurate modification of enzyme concentrations 
in the in vitro pathway make it possible to quantitatively 
evaluate the impact of different enzymes on the pathway 
flux based on metabolic control analysis. Subsequently 
key enzymes in the pathway can be determined and the 
overexpression of these enzymes is more likely to be an 
effective strain modification strategy to improve the 
pathway flux in vivo. The enzyme LysC (usually respon-
sible for lysine synthesis) showed the largest impact on 
threonine synthesis in our threonine production strain 
Thr. A modified strain with overexpressed LysC produced 
30% more threonine compared with the original strain. 
It should be noted that in a different E. coli strain other 
enzymes rather than LysC might be key enzymes in thre-
onine synthesis. However, the method developed in this 
study is still useful for key enzyme determination in dif-
ferent cells and different pathways. With the construction 
of even complex in vitro pathways (e.g. the whole central 
Figure 8 The pathway flux (J) in the vitro system when enzyme concentration was increased. a The pathway flux in the system caused by crude 
enzyme extract without addition of purified enzyme. b The pathway flux when purified LysC was added to the crude enzyme extract. The good 
linear relationships between threonine concentration and reaction time indicate that the in vitro pathway was at pseudo-steady state during that 
time period. Therefore the threonine production rates calculated from the linear relationship can represent the pathway fluxes. Three replicates of 
this experiment.
Figure 9 Flux control coefficients of the enzymes in the threonine 
synthesis pathway. LysC has the largest control coefficient and thus 
is the key enzyme for threonine synthesis. Three replicates of this 
experiment.
Figure 10 Comparison of the fermentation results of the original 
Thr strain and the LysC overexpressed strain. Two replicates of this 
experiment.
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pathway), the method can provide versatile insights for 
understanding the regulation and organization of meta-
bolic pathways and subsequently discover unusual novel 




The substrates aspartate, NADPH, ATP, PLP and the 
inhibitors for the enzymes reaction lysine, methionine, 
and threonine were purchased from Sigma (USA), the 
restriction enzymes and PCR mix were purchased from 
Fermentas (USA). Na2HPO4 and other organic solvents 
used for HPLC were purchased from Merck (German). 
Other chemicals used in this article otherwise demon-
strated were purchased from Solarbio (Beijing, China). 
The kits and markers used for the construction of clones 
were from Transgen (Beijing, China). The protein mark-
ers and SDS-PAGE gels were purchased from life tech-
nologies (USA).
The fermentation of threonine production strains 
and sampling
The crude enzyme extract was prepared from threonine 
production strain Thr. The cells were grown 8  h in LB 
shake flask cultures and then were inoculated in 3.5  L 
fermentation medium (composed of 80  g glucose, 4  g 
(NH4)2SO4, 0.02  g Ile, 2  g KH2PO3, 1  g MgSO4·7H2O, 
4  g yeast extract powder, 0.015  g FeSO4·7H2O, 0.015  g 
MnSO4·H2O and 1  g lycine of every 1  L medium). The 
fermentation temperature was 37°C, pH was controlled 
at 7.0 and glucose concentration in the fermentation 
was controlled between 0 and 5  g/L. The fermentation 
broth was sampled every 2  h for threonine production 
and cell density analysis. A sample obtained at expo-
nential growth phase and with high threonine produc-
tion rate was used for proteomics analysis and crude 
enzyme extract experiments. The cells were harvested by 
centrifugation at 6,000g for 30 min at 4°C. For the crude 
enzyme extract preparation, the cells were washed three 
times with enzyme assay buffer (23  mM Tes, 114  mM 
KCl, 6  mM MgCl2, pH 7.5) and were disrupted by high 
pressure homogenizer. The cells lysate was centrifuged at 
12,000g for 30 min at 4°C to remove cell debris. Then the 
supernatant was dialyzed to remove small molecules. The 
final crude enzyme extracts were stored at −80°C after 
flash freezing with liquid nitrogen for further proteomics 
analysis and crude enzyme extract experiments.
Proteomics analysis
The cells were the same as those for preparation of 
the cell crude extract. About 100  mg wet mass were 
processed through single tube whole cell lysis and protein 
digestion. Cells were frozen by Liquid nitrogen immedi-
ately after centrifugation and washed three times with 
phosphate buffer (pH 7.0). The cells were then resus-
pended in a lysis buffer (Tris–HCl 0.1  M, pH 7.6, DTT 
0.1 M) and broken with sonication cracking on ice with 
the parameters set as follows: 5 s on, 5 s off, total 15 min 
using the sonification device made in Nanjing. After 
sonication the supernatant was centrifuged for 20  min 
at 16,000g. The supernatant was filtered through sterile 
membrane filter (0.22  μm) and then transferred into a 
new tube. After boiling for 10  min the supernatant was 
stored at −80°C prior to sample cleanup if not for imme-
diate use. The protein pellet extracted from previous step 
was quantitated using 2D-Quant Kit (purchased from GE 
healthcare). And then protein pellet from previous step 
was washed by UA buffer [8 M Urea dissolved in 0.1 M 
Tris–HCl (pH 8.5)] and dissolved in digestion buffer 
[100  mM TEAB (triethylammonium bicarbonate)] to a 
final concentration of 1 mg/mL. Equal aliquots were then 
digested with trypsin overnight at 37°C (Promega).
A NanoLC system (NanoLC 2D Ultra, Eksigent) 
equipped with Triple TOF 5600 mass spectrometer 
(AB SCIEX, USA) was used for analysis. Peptides were 
trapped on NanoLC pre-column (Chromxp C18, 3 μm, 
size 0.35  ×  10  mm) and then eluted onto an analytical 
column (chromxp C18, 3 μm, size 0.075 × 150 mm) and 
separated by a 60  min gradient from 5 to 60% Buffer B 
(98% ACN, 2% H2O, 0.1% FA) at a flow rate of 300  nL/
min. Full-scan MS was performed in positive ion mode 
with nano-ion spray voltage of 2.5 kv from 350 to 1,500 
(m/z). For IDA, survey scans were acquired in 250 ms and 
as many as 30 product ion scans were collected if exceed-
ing a threshold of 125 counts per second (counts/s) and 
with a + 2 to a + 5 charge-state.
Plasmid construction
The genomic DNA from Thr was used as the template 
for amplification of the threonine synthesis genes. The 
pET28a based plasmids were constructed for the purifi-
cation of the enzymes with six histidine residues at N-ter-
minus. The genes were amplified using primers shown in 
Table 2, after amplification the genes were inserted into 
pET28a vector using restriction enzymes and T4 DNA 
ligase. The plasmids and strains used in this study were 
shown in Table 3.
Enzyme expression and purification
To purify the enzymes, the corresponding plasmids were 
introduced into E. coli BL21 (DE3). Single colonies were 
grown in LB medium with 50 μg/mL Kanamycin at 37°C 
until OD600 of the culture reached 0.6–0.8. Cultures were 
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cooled to 16°C, and IPTG was added to a final concentra-
tion of 1 mM. After further growth at 16°C for 14–16 h, 
the cells were harvested by centrifugation at 6,000g for 
30  min at 4°C, the supernatant was discarded. The pel-
let was suspended with buffer A (150  mM Tris–HCl, 
150 mM NaCl and 20 mM imidazole, 1 mM DTT, pH 7.5) 
and the cells were disrupted by high pressure homog-
enizer. Then the cell lysate was centrifuged at 12,000g for 
30 min at 4°C to remove cell debris. The supernatant was 
loaded onto Ni–NTA His-Bind column (GE Healthcare). 
The purification process was conducted on the protein 
purification machine AKTA purifier 10 with linear gra-
dient imidazole from 20  mM to 500  mM in buffer. The 
fraction with higher OD280 was selected for SDS-PAGE. 
The fraction with pure protein was selected for dialysis in 
order to remove imidazole. After purification, the puri-
fied enzymes were quantitated using 2D-Quant Kit (pur-
chased from GE healthcare) and purity was accessed by 
SDS-PAGE. The freshly purified proteins were stored at 
−80°C until use.
Assay of the enzyme activities
The activities of aspartate kinase in the crude enzyme 
extract were measured in a coupled assay with pyru-
vate kinase (PK) and lactate dehydrogenase (LDH) as 
described by Chassagnole and his colleagues [24] by fol-
lowing the NADH oxidation at 340 nm at 37°C. The reac-
tion mixture contained in 200 μL of assay buffer, 5 mM 
aspartate, 5  mM ATP, 1.5  mM phosphoenolpyruvate, 
0.3  mM NADH, 2.5  U PK, 2.5  U LDH and appropriate 
amount of crude enzyme extract. To investigate the con-
tribution of different isoenzymes to the first reaction, 
10 mM lysine and 10 mM methionine (enough to inhibit 
the corresponding isoenzyme) were added to the reac-
tion system separately.
The activities of purified enzymes were assayed with 
detection of threonine after all five enzymes added. The 
reaction systems were as follows: 5 mM ASP, 5 mM ATP, 
10  mM NADPH, 0.5  mM PLP, the concentrations of 
LysC, ThrA, Asd, ThrB, ThrC were all 100 nM. The reac-
tion was conducted at 37°C for 0.5 h. The reaction liquid 
Table 2 PCR primers used in this study
Enzyme name Prime name Primer sequence (5′–3′)
ThrA thrA_F1 GGGAATTCCATATG ATGCGAGTGTTGAAGTTCGGCGGTA
thrA_R1 CCGGAATTCTCAGACTCCTAACTTCCATGAGAGG
LysC lysC_F1 GGGAATTCCATATG ATGTCTGAAATTGTTGTCTCCAAAT
lysC_R1 CCGGAATTCTTACTCAAACAAATTACTATGCAGT






LysC lysC_F2 CCG GAATTCATG ATGTCTGAAATTGTTGTCTCCAAAT
lysC_R2 CGC GGATCCTTACTCAAACAAAT TACTATGC AGT
Table 3 Strains and plasmids used in this research
Strains and plasmids Description
Thr The genome of this strain was used as the template for amplification of threonine synthesis genes
E. coli DH5a This strain was used for the clone of the plasmid
E. coli BL21 This strain was used for enzyme protein expression
pET28a-thrA N-terminal His-tagged thrA, inserted between NdeI and EcoRI sites of pET 28a (+)
pET28a-lysC N-terminal His-tagged lysC, inserted between NdeI and EcoRI sites of pET 28a (+)
pET28a-asd N-terminal His-tagged asd, inserted between NheI and EcoRI sites of pET 28a (+)
pET28a-thrB N-terminal His-tagged thrB, inserted between NdeI and EcoRI sites of pET 28a (+)
pET28a-thrC N-terminal His-tagged thrC, inserted between NdeI and BamHI sites of pET 28a (+)
pWSK29-lysC lysC, inserted between EcoRI and BamHI sites of pWSK29
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was heated at 100°C for 10 min to inactivate the enzymes 
when the reaction finished. After inactivation the liquid 
was centrifuged at 12,000g for 20  min and used for the 
assay of threonine by HPLC using the method provided 
by Agilent Company. The mobile phase A was 40  mM 
Na2HPO4, pH 7.8, mobile B was ACN:MeOH:water 
(45:45:10, v/v/v). The flow rate was 2 mL/min. The same 
procedure was used for crude enzyme extract activity 
analysis. There were three replicates of each assay.
In vivo validation of the key enzyme
For the in vivo validation of the key enzyme identified 
from the in vitro enzyme reactions, the overexpres-
sion plasmid was constructed using pWSK29 and prim-
ers named as lysC_F2 and lysC_R2 (shown in Table 2) in 
order to distinguish them from those used for construc-
tion of LysC expression plasmid. Thr strain containing 
the LysC overexpression plasmid was fermented and 
the fermentation process was the same as those in the 
fermentation of Thr strain for samples of crude enzyme 
extracts preparation.
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